| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a88d8527d6dd99bc71959eb18cb3dd9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
| filingDate |
2005-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c73ecd7ee48d860d8398996952e4b98 |
| publicationDate |
2007-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
IE-20050699-A1 |
| titleOfInvention |
Anti-steroid infection treatment |
| abstract |
Mineralocorticoid receptor blockers are disclosed for use in the prophylaxis and therapy of viral infections, especially the retroviral infection of HIV. These compounds can be administered alone or in combination with conventional anti-viral agents or anti-sense mRNA or DNA mutants of heat shock proteins. |
| priorityDate |
2005-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |